Sodium Nitroprusside
 OpenBabel02212023462D

 15 12  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 Na  0  3  0  0  0 15  0  0  0  0  0  0
    3.6536    0.0550    0.0000 Fe  0  6  0  0  0  0  0  0  0  0  0  0
    4.0661    0.7694    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.8911    0.7694    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.2411   -0.6595    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8286   -1.3740    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.0661   -0.6595    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4786   -1.3740    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.4786    0.0550    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3036    0.0550    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.2411    0.7694    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8286    1.4839    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.8286    0.0550    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0036    0.0550    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000   -3.0240    0.0000 Na  0  3  0  0  0 15  0  0  0  0  0  0
  2  3  1  0  0  0  0
  2  5  1  0  0  0  0
  2  7  1  0  0  0  0
  2  9  1  0  0  0  0
  2 11  1  0  0  0  0
  2 13  1  0  0  0  0
  3  4  2  0  0  0  0
  5  6  3  0  0  0  0
  7  8  3  0  0  0  0
  9 10  3  0  0  0  0
 11 12  3  0  0  0  0
 13 14  3  0  0  0  0
M  CHG  3   1   1   2  -2  15   1
M  END
>  <CdId>
82

>  <Mol Weight>
261.918

>  <Formula>
C5FeN6Na2O

>  <ID>
T0003

>  <Name>
Sodium Nitroprusside

>  <Synonyms>
Ro 21-2498;Sodium Nitroferricyanide

>  <CAS>
14402-89-2

>  <Approved status>
FDA

>  <Disease>
Cardiovascular system

>  <Indication>
Hypertension

>  <Pathways>
Others

>  <Target>
Others

>  <Receptor>
Atrial natriuretic peptide receptor 1

$$$$
